Mucosal targeting immunisation

Details Mucosal targeting immunisation Mucosal targeting immunisation

A - Human Necessities

61

K

A61K 39/21 (2006.01) A61K 39/00 (2006.01) A61K 39/02 (2006.01) A61K 39/118 (2006.01) A61K 39/12 (2006.01) A61K 39/245 (2006.01) C07K 14/16 (2006.01)

Patent

CA 2335506

The invention concerns the use of an immunogen specific of a pathogenic agent having a gateway in a mucous membrane for producing an immunogenic composition to be administered to a human by parenteral route at the surface of part of the body distinct from the mucous membrane so as to directly develop a local response in IgA, IgG and/or IgM antibody in said mucous membrane.

Utilisation d'immunogène spécifique d'un agent pathogène ayant une porte d'entrée au niveau d'une muqueuse pour la production d'une composition immunogène destinée à être administrée chez l'homme par voie parentérale à la surface d'une partie du corps distincte de ladite muqueuse, de manière à directement développer une réponse locale en anticorps IgA, IgG et/ou IgM au niveau de ladite muqueuse.

Affiliated with

Also associated with

Rating

Mucosal targeting immunisation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mucosal targeting immunisation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mucosal targeting immunisation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1466563